Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer

Daisuke Asahi

首页> 外文期刊>Japanese Journal of Clinical Oncology >Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer

【24h】

Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer

机译：肿瘤KRAS状态可预测日本转移性结直肠癌患者对Panitumumab的反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2011年第2期|p.210-216|共7页
作者
Daisuke Asahi;
展开▼
作者单位

For reprints and all correspondence: Toshihiko Doi, National Cancer Center Hospital East, Gastrointestinal/Oncology Division, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken 277-8577, Japan. E-mail:;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Tumor KRAS status predicts responsiveness to panitumumab in Japanese patients with metastatic colorectal cancer. [J] . Doi T, Tahara M, Yoshino T, Japanese journal of clinical oncology. . 2011,第2期

机译：肿瘤的KRAS状态可预测日本转移性结直肠癌患者对panitumumab的反应性。
2. EFFICACY AND SAFETY OF PANITUMUMAB IN PATIENTS OF METASTATIC COLORECTAL CANCER BY TUMOR KRAS STATUS: A SYSTEMATIC REVIEW [J] . Singh R., Sharma N., Rana P., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：转移性大肠癌患者按肿瘤KRAS病的疗效和安全性的系统评价
3. The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or irinotecan in second-line therapy for metastatic colorectal cancer: The secondary analysis from STEPP (skin toxicity evaluation protocol with panitumumab) by KRAS status [J] . Clinical colorectal cancer . 2011,第4期

机译：帕尼单抗与FOLFIRI或伊立替康同时给药在转移性结直肠癌二线治疗中的功效和安全性：STEP的二次分析（帕尼单抗的皮肤毒性评估方案）通过KRAS状态进行二次分析
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Comparative Analysis on Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells [D] . Santos, Mark Anthony Francisco. 2014

机译：转移性乳腺癌，结直肠癌和前列腺癌患者循环肿瘤细胞先天免疫系统功能的比较分析
6. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in metastatic colorectal cancer (mCRC) patients treated with salvage cetuximab/panitumumab monotherapy [O] . Zenia Saridaki, Joanne B. Weidhaas, Heinz-Josef Lenz, -1

机译：KRAS的let-7 microRNA结合位点多态性预测接受挽救性西妥昔单抗/帕尼单抗单药治疗的转移性结直肠癌（mCRC）患者的转归改善
7. Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer [O] . T. Doi, M. Tahara, T. Yoshino, 2010

机译：肿瘤KRAS状态预测日本转移性结直肠癌患者Panitumumab的反应性

Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer

著录项

相似文献

相关主题

期刊订阅